Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing - Ana Homšek Ilić; Marija Jovanović; Srđan Marković; Sandra Vezmar Kovačević; Tamara Knežević Ivanovski; Đorđe Kralj; Petar Svorcan; Katarina Vučićević (PLoS ONE, 2026)